The “Hidden Gem” Countries for Pharma Talent

About this recording

The pharmaceutical and life sciences sector is moving quickly. R&D pipelines continue to expand, clinical trials are becoming more globally distributed, and regulatory environments are evolving at different speeds across regions. At the same time, the skills needed to support advanced manufacturing, AI-driven drug discovery, quality compliance, and clinical operations are becoming more specialized and more competitive.

In this on-demand session, Safeguard Global and Alphanumeric share perspectives on how pharma organizations are broadening their country consideration set to access specialized talent, and how to evaluate new talent markets in a way that balances opportunity with compliance, speed, and operational complexity.

You’ll hear insights on

• The dynamics reshaping pharma talent markets and global hiring decisions
• What key talent clusters signal about long-term capability building
• How to evaluate new talent markets with greater precision, not just cost alone
• Execution considerations that influence successful hiring across borders

Whether your priority is expanding into new markets, accessing specialized capabilities, or improving the way you execute global hiring, this session offers guidance to help you make smarter talent decisions in 2026.